CPL-976

N/A

Report date: 2024/06/24 11:33:18

Base Information

Drug NameCPL-976

Drug Alias NameCPL-976CPL976CPBT-0976

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Programmed death-ligand 1Anti-AXL receptor tyrosine kinase

TargetsProgrammed death-ligand 1AXL receptor tyrosine kinase

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPoland

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCelon Pharma Sa

China Registration ClassN/A

Develop Information

Active CompaniesCelon Pharma Sa

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A